Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pennsaid 2% for Grade I–II Ankle Sprain
2016-002620-92Phase 3Completed
- Sponsor
- Miravo Healthcare
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Elfenor in Ankle sprain, sponsored by Miravo Healthcare. Primary endpoint: Pain on movement on Day 3. Started Aug 2016; status: completed.
02
Drugs
Elfenor
03
Conditions
Ankle sprain
Beyond the preview
Go deeper on 2016-002620-92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002620-92.